View in EDS

PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.

Saved in:
Bibliographic Details
Title: PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.
Authors: Martinez FJ; Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France., White M; Infectious Disease Epidemiology and Analytics G5 Unit, Institut Pasteur, Université Paris Cité, Paris, France., Guillotte-Blisnick M; Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France., Huon C; Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France., Boucharlat A; Chemogenomic and Biological Screening Core Facility, C2RT, Institut Pasteur, Université Paris Cité, CNRS UMR 3523, Paris, France., Agou F; Chemogenomic and Biological Screening Core Facility, C2RT, Institut Pasteur, Université Paris Cité, CNRS UMR 3523, Paris, France., England P; Molecular Biophysics Facility, CNRS UMR 3528, Institut Pasteur, Paris, France., Popovici J; Malaria Reasearch Unit, Institut Pasteur du Cambodge, Pnom Penh, Cambodia., Hou MM; Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.; The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK., Silk SE; Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.; The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK., Barrett JR; Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.; The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK., Nielsen CM; Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.; The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK., Reimer JM; Novavax AB, Kungsgatan 109, SE-753 18, Uppsala, Sweden., Mukherjee P; Multi-Vaccines Development Program, ICGEB Campus, New Delhi, India., Chauhan VS; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India., Minassian AM; Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.; The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Draper SJ; Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.; The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Chitnis CE; Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France. chetan.chitnis@pasteur.fr.
Source: NPJ vaccines [NPJ Vaccines] 2024 Jan 06; Vol. 9 (1), pp. 10. Date of Electronic Publication: 2024 Jan 06.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38184681
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Martinez+FJ%22">Martinez FJ</searchLink>; Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22White+M%22">White M</searchLink>; Infectious Disease Epidemiology and Analytics G5 Unit, Institut Pasteur, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Guillotte-Blisnick+M%22">Guillotte-Blisnick M</searchLink>; Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Huon+C%22">Huon C</searchLink>; Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Boucharlat+A%22">Boucharlat A</searchLink>; Chemogenomic and Biological Screening Core Facility, C2RT, Institut Pasteur, Université Paris Cité, CNRS UMR 3523, Paris, France.<br /><searchLink fieldCode="AU" term="%22Agou+F%22">Agou F</searchLink>; Chemogenomic and Biological Screening Core Facility, C2RT, Institut Pasteur, Université Paris Cité, CNRS UMR 3523, Paris, France.<br /><searchLink fieldCode="AU" term="%22England+P%22">England P</searchLink>; Molecular Biophysics Facility, CNRS UMR 3528, Institut Pasteur, Paris, France.<br /><searchLink fieldCode="AU" term="%22Popovici+J%22">Popovici J</searchLink>; Malaria Reasearch Unit, Institut Pasteur du Cambodge, Pnom Penh, Cambodia.<br /><searchLink fieldCode="AU" term="%22Hou+MM%22">Hou MM</searchLink>; Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.; The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.<br /><searchLink fieldCode="AU" term="%22Silk+SE%22">Silk SE</searchLink>; Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.; The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.<br /><searchLink fieldCode="AU" term="%22Barrett+JR%22">Barrett JR</searchLink>; Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.; The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.<br /><searchLink fieldCode="AU" term="%22Nielsen+CM%22">Nielsen CM</searchLink>; Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.; The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.<br /><searchLink fieldCode="AU" term="%22Reimer+JM%22">Reimer JM</searchLink>; Novavax AB, Kungsgatan 109, SE-753 18, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Mukherjee+P%22">Mukherjee P</searchLink>; Multi-Vaccines Development Program, ICGEB Campus, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Chauhan+VS%22">Chauhan VS</searchLink>; International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Minassian+AM%22">Minassian AM</searchLink>; Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.; The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Draper+SJ%22">Draper SJ</searchLink>; Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.; The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Chitnis+CE%22">Chitnis CE</searchLink>; Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France. chetan.chitnis@pasteur.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101699863%22">NPJ vaccines</searchLink> [NPJ Vaccines] 2024 Jan 06; Vol. 9 (1), pp. 10. <i>Date of Electronic Publication: </i>2024 Jan 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+in+partnership+with+the+Sealy+Center+for+Vaccine+Development%22">Springer Nature in partnership with the Sealy Center for Vaccine Development </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101699863 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-0105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220590105%22">20590105 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Vaccines <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38184681
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41541-023-00796-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 10
    Titles:
      – TitleFull: PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martinez FJ
      – PersonEntity:
          Name:
            NameFull: White M
      – PersonEntity:
          Name:
            NameFull: Guillotte-Blisnick M
      – PersonEntity:
          Name:
            NameFull: Huon C
      – PersonEntity:
          Name:
            NameFull: Boucharlat A
      – PersonEntity:
          Name:
            NameFull: Agou F
      – PersonEntity:
          Name:
            NameFull: England P
      – PersonEntity:
          Name:
            NameFull: Popovici J
      – PersonEntity:
          Name:
            NameFull: Hou MM
      – PersonEntity:
          Name:
            NameFull: Silk SE
      – PersonEntity:
          Name:
            NameFull: Barrett JR
      – PersonEntity:
          Name:
            NameFull: Nielsen CM
      – PersonEntity:
          Name:
            NameFull: Reimer JM
      – PersonEntity:
          Name:
            NameFull: Mukherjee P
      – PersonEntity:
          Name:
            NameFull: Chauhan VS
      – PersonEntity:
          Name:
            NameFull: Minassian AM
      – PersonEntity:
          Name:
            NameFull: Draper SJ
      – PersonEntity:
          Name:
            NameFull: Chitnis CE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 01
              Text: 2024 Jan 06
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2059-0105
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ vaccines
              Type: main
ResultId 1